Emmaus Life Sciences, Inc. SEC filings EMMA

Emmaus Life Sciences, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Sep 2, 2009. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.

Emmaus Life Sciences, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Results of operations
May 15, 2026 May 15, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Officer or director change
Apr 17, 2026 Apr 16, 2026
8-K Current report
Officer or director change
Apr 14, 2026 Apr 13, 2026
8-K Current report
Results of operations
Mar 31, 2026 Mar 30, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Material agreement
Mar 4, 2026 Mar 2, 2026
8-K Current report
Material agreement, Other events
Dec 31, 2025 Dec 24, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
Dec 22, 2025 Dec 17, 2025
8-K Current report
Officer or director change
Dec 19, 2025 Dec 15, 2025
8-K Current report
Results of operations
Nov 14, 2025 Nov 14, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Officer or director change
Jul 1, 2025 Jun 30, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Auditor change
May 6, 2025 May 2, 2025
8-K Current report
Results of operations
Apr 14, 2025 Apr 14, 2025
10-K Annual report Apr 14, 2025 Dec 31, 2024
NT 10-K Notification of late filing Apr 1, 2025 Dec 31, 2024
8-K Current report
Results of operations
Nov 19, 2024 Nov 19, 2024
10-Q Quarterly report Nov 19, 2024 Sep 30, 2024
NT 10-Q Notification of late filing Nov 14, 2024 Sep 30, 2024
8-K Current report
Officer or director change
Nov 6, 2024 Nov 4, 2024
8-K Current report
Auditor change
Oct 25, 2024 Oct 22, 2024
8-K Current report
Officer or director change
Oct 4, 2024 Sep 30, 2024
8-K Current report
Results of operations, Auditor change
Sep 10, 2024 Sep 5, 2024
10-Q Quarterly report Sep 10, 2024 Jun 30, 2024
10-Q Quarterly report Sep 10, 2024 Mar 31, 2024
NT 10-Q Filing Aug 15, 2024 Jun 30, 2024
8-K Current report
Officer or director change
Jul 17, 2024 Jul 15, 2024
8-K Current report
Results of operations
Jul 3, 2024 Jul 3, 2024
10-K Annual report Jul 3, 2024 Dec 31, 2023
8-K Current report
Bylaw or fiscal year change
May 28, 2024 May 23, 2024
NT 10-K Notification of late filing Apr 1, 2024 Dec 31, 2023
8-K Current report
Material agreement, New debt, Unregistered share sale
Feb 26, 2024 Feb 21, 2024
8-K Current report
Material agreement, Unregistered share sale
Dec 20, 2023 Dec 15, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Officer or director change
Oct 4, 2023 Oct 2, 2023
8-K Current report
Officer or director change
Aug 23, 2023 Aug 18, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Results of operations
May 15, 2023 May 15, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Results of operations
Mar 31, 2023 Mar 31, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
8-K Current report
Unregistered share sale
Mar 7, 2023 Jan 18, 2023
D Filing Jan 31, 2023 —
D Filing Jan 20, 2023 —
8-K Current report
Unregistered share sale, Officer or director change
Jan 19, 2023 Jan 12, 2023
8-K Current report
Shareholder vote results
Dec 12, 2022 Dec 8, 2022
8-K Current report
Results of operations
Nov 15, 2022 Nov 14, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
DEF 14A Proxy statement Oct 31, 2022 Dec 8, 2022
PRE 14A Preliminary proxy statement Oct 21, 2022 Dec 8, 2022
8-K Current report
Officer or director change
Oct 6, 2022 Oct 4, 2022
8-K Current report
Officer or director change
Sep 30, 2022 Sep 28, 2022
8-K Current report
Material agreement, New debt
Aug 19, 2022 Aug 15, 2022
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Officer or director change
Aug 10, 2022 Aug 4, 2022
10-K/A Amended annual report Jul 1, 2022 Dec 31, 2021
D Filing Jun 30, 2022 —
8-K Current report
Officer or director change
Jun 10, 2022 Jun 8, 2022
8-K Current report
Results of operations
May 13, 2022 May 13, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
8-K Current report
Results of operations
Mar 31, 2022 Mar 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
8-K Current report
Officer or director change
Jan 10, 2022 Jan 6, 2022
S-8 Employee stock plan registration Dec 30, 2021 —
8-K Current report
Officer or director change, Shareholder vote results
Nov 29, 2021 Nov 23, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
DEF 14A Proxy statement Oct 12, 2021 Nov 23, 2021
8-K Current report
Material agreement
Oct 12, 2021 Oct 7, 2021
PRE 14A Preliminary proxy statement Sep 30, 2021 Nov 23, 2021
10-Q Quarterly report Sep 1, 2021 Jun 30, 2021
10-Q Quarterly report Sep 1, 2021 Mar 31, 2021
10-Q Quarterly report Aug 26, 2021 Jun 30, 2020
10-Q Quarterly report Aug 26, 2021 Sep 30, 2020
10-Q Quarterly report Aug 26, 2021 Mar 31, 2020
10-K/A Amended annual report Aug 10, 2021 Dec 31, 2020
8-K Current report
Restatement
Aug 10, 2021 Aug 5, 2021
8-K Current report
Other events
May 19, 2021 May 19, 2021
NT 10-Q Notification of late filing May 17, 2021 Mar 31, 2021
10-K Annual report May 4, 2021 Dec 31, 2020
NT 10-K Notification of late filing Mar 31, 2021 Dec 31, 2020
8-K Current report
Material agreement, New debt
Feb 22, 2021 Feb 22, 2021
D Filing Feb 16, 2021 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Feb 16, 2021 Feb 9, 2021
10-K Annual report Jan 25, 2021 Dec 31, 2019
8-K Current report
Material agreement, New debt
Nov 13, 2020 Oct 28, 2020
8-K Current report
Auditor change
Nov 5, 2020 Nov 1, 2020
8-K Current report
Regulation FD disclosure
Oct 29, 2020 Oct 29, 2020
8-K Current report
Material agreement
Oct 20, 2020 Sep 28, 2020
D/A Filing Oct 9, 2020 —
8-K/A Amended current report
Unregistered share sale
Oct 8, 2020 Sep 22, 2020
D/A Filing Oct 7, 2020 —
D Filing Oct 7, 2020 —
8-K/A Amended current report Sep 25, 2020 Sep 10, 2020
8-K Current report
Material agreement, New debt
Sep 24, 2020 Sep 22, 2020
8-K Current report
Auditor change
Sep 17, 2020 Sep 10, 2020
8-K Current report
Officer or director change
Sep 1, 2020 Sep 1, 2020
D Filing Aug 7, 2020 —
8-K Current report
Other events
Jul 31, 2020 Jul 31, 2020
8-K Current report
Restatement
Jul 8, 2020 Jul 1, 2020
NT 10-Q Notification of late filing May 18, 2020 Mar 31, 2020
NT 10-K Filing May 15, 2020 Dec 31, 2019
8-K/A Amended current report
Other events
Apr 30, 2020 Mar 27, 2020
8-K Current report
Officer or director change
Mar 31, 2020 Mar 25, 2020
8-K Current report
Other events
Mar 27, 2020 Mar 27, 2020
424B5 Prospectus supplement Mar 3, 2020 —
8-K Current report
Material agreement, Other events
Mar 3, 2020 Feb 28, 2020
8-K Current report
Material agreement, New debt
Feb 27, 2020 Feb 27, 2020
8-K Current report
Auditor change
Jan 6, 2020 Dec 30, 2019
8-K Current report
Material agreement
Dec 23, 2019 Dec 23, 2019
10-Q Quarterly report Nov 13, 2019 Sep 30, 2019
8-K Current report
Other events
Nov 12, 2019 Nov 12, 2019
25-NSE Delisting notice Nov 8, 2019 —
8-K Current report
Other events
Oct 29, 2019 Oct 25, 2019
424B5 Prospectus supplement Oct 25, 2019 —
8-K Current report
Auditor change
Oct 24, 2019 Oct 18, 2019
8-K Current report
Other events
Oct 11, 2019 Oct 11, 2019
8-K Current report
Officer or director change
Oct 1, 2019 Sep 30, 2019
8-K Current report
Bylaw or fiscal year change
Sep 30, 2019 Sep 25, 2019
S-8 Employee stock plan registration Sep 12, 2019 —
8-K Current report
Listing notice, Other events
Sep 10, 2019 Sep 9, 2019
8-K/A Amended current report Aug 14, 2019 Jul 16, 2019
10-Q Quarterly report Aug 14, 2019 Jun 30, 2019
8-K Current report
Acquisition or sale of assets, Listing notice, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
Jul 22, 2019 Jul 16, 2019
8-K Current report
Shareholder vote results
Jul 12, 2019 Jul 9, 2019
8-K Current report
Other events
Jul 9, 2019 Jul 9, 2019
425 Current report Jul 9, 2019 —
8-K Current report
Material agreement, Change to shareholder rights, Officer or director change
Jun 28, 2019 Jun 25, 2019
8-K Current report
Regulation FD disclosure
Jun 20, 2019 Jun 18, 2019
424B3 Prospectus Jun 14, 2019 —
EFFECT Filing Jun 11, 2019 —
CORRESP Letter to the SEC Jun 11, 2019 —
S-4/A Amendment no. 2 to s-4 Jun 11, 2019 —
S-4/A Amendment no. 1 to registration statement Jun 10, 2019 —
8-K Current report
Material agreement
Jun 10, 2019 May 30, 2019
UPLOAD Letter from the SEC May 30, 2019 —
424B5 Prospectus supplement May 24, 2019 —
425 Filing May 23, 2019 —
8-K Current report
Material agreement, Regulation FD disclosure
May 23, 2019 May 22, 2019
8-K Current report
Regulation FD disclosure, Other events
May 13, 2019 May 13, 2019
425 Form 8-k May 13, 2019 —
10-Q Quarterly report May 13, 2019 Mar 31, 2019
CORRESP Letter to the SEC May 9, 2019 —
UPLOAD Letter from the SEC May 2, 2019 —
8-K Current report
Other events
Apr 17, 2019 Apr 17, 2019
425 8-k Apr 17, 2019 —
8-K Current report
Regulation FD disclosure, Other events
Apr 4, 2019 Apr 4, 2019
425 8-k Apr 4, 2019 —
8-K Current report
Regulation FD disclosure, Other events
Mar 5, 2019 Feb 28, 2019
425 8-k Mar 5, 2019 —
UPLOAD Letter from the SEC Feb 25, 2019 —
8-K Current report
Listing notice, Other events
Feb 22, 2019 Feb 21, 2019
425 Form 8-k Feb 22, 2019 —
8-K Current report
Other events
Feb 14, 2019 Feb 14, 2019
425 Form 8-k Feb 14, 2019 —
10-Q Quarterly report Feb 14, 2019 Dec 31, 2018
S-4 Registration for a merger or exchange Feb 13, 2019 —
8-K Current report
Other events
Feb 4, 2019 Feb 4, 2019
425 Form 8k Feb 4, 2019 —
425 Filing Jan 29, 2019 —
425 Filing Jan 10, 2019 —
8-K Current report
Material agreement, Change in control, Other events
Jan 7, 2019 Jan 4, 2019
425 Form 8-k Jan 7, 2019 —
425 Filing Jan 7, 2019 —
424B3 Prospectus Dec 26, 2018 —
EFFECT Filing Dec 21, 2018 —
CORRESP Letter to the SEC Dec 20, 2018 —
UPLOAD Letter from the SEC Dec 20, 2018 —
S-8 Employee stock plan registration Dec 14, 2018 —
S-1 Registration statement Dec 14, 2018 —
8-K Current report
Officer or director change
Dec 12, 2018 Dec 12, 2018
10-K Annual report Dec 11, 2018 Sep 30, 2018
8-K Current report
Shareholder vote results
Nov 30, 2018 Nov 26, 2018
DEF 14A Proxy statement Nov 2, 2018 Nov 26, 2018
PRE 14A Preliminary proxy statement Oct 23, 2018 Oct 23, 2018
8-K Current report
Officer or director change
Oct 12, 2018 Oct 8, 2018
8-K Current report
Material agreement, Unregistered share sale
Sep 26, 2018 Sep 21, 2018
8-K Current report
Regulation FD disclosure
Sep 6, 2018 Sep 6, 2018
8-K Current report
Regulation FD disclosure
Aug 16, 2018 Aug 14, 2018
8-K Current report
Results of operations
Aug 13, 2018 Aug 13, 2018
10-Q Quarterly report Aug 10, 2018 Jun 30, 2018
EFFECT Filing Jun 29, 2018 —
CORRESP Letter to the SEC Jun 28, 2018 —
EFFECT Filing Jun 8, 2018 —
EFFECT Filing Jun 8, 2018 —
424B3 Prospectus Jun 8, 2018 —
S-3/A Filing Jun 8, 2018 —
8-K/A Amended current report
Other events
May 24, 2018 May 22, 2018
8-K Current report
Other events
May 22, 2018 May 22, 2018
S-3 Shelf registration May 22, 2018 —
S-1 Registration statement May 18, 2018 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
EMMA (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Torrance, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
822370
Former names
MYnd Analytics, Inc. (until Jul 12, 2019); CNS RESPONSE, INC. (until Dec 10, 2015); STRATIVATION, INC. (until Mar 1, 2007); SalesTactix, Inc. (until Aug 23, 2005); AGE RESEARCH INC (until Aug 5, 2004)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.